Form 4: Pediatrix Medical Group CEO James D. Swift Reports Stock Disposal for Tax Obligations
SEC Form 4 Filing
James D. Swift, CEO of Pediatrix Medical Group, disposed of 14,938 shares of common stock on March 1, 2024, to cover tax obligations upon vesting of shares.
Summary
- On March 1, 2024, James D. Swift, the CEO of Pediatrix Medical Group, disposed of 14,938 shares of common stock.
- The disposal was executed to cover tax obligations related to the vesting of restricted shares.
- The price per share for the transaction was $9.15.
- Following the transaction, Swift directly owns 75,936 shares of Pediatrix Medical Group.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing a routine transaction (disposal of shares for tax obligations). It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This transaction is related to tax obligations, which is a common reason for stock disposals by executives.
Stakeholder Impact
- The transaction is unlikely to have a significant impact on stakeholders as it is a routine disposal of shares for tax purposes.
Key Dates
| Date | Description |
|---|---|
| 03/01/2024 | Date of stock disposal transaction |
| 03/05/2024 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.